Angel, K., Provan, S. A., Mowinckel, P., Seljeflot, I., Kvien, T. K., & Atar, D. (2012). The l-arginine/asymmetric dimethylarginine ratio is improved by anti-Tumor Necrosis Factor–α therapy in inflammatory arthropathies. Associations with aortic stiffness. Atherosclerosis (00219150), 225(1), 160. https://doi.org/10.1016/j.atherosclerosis.2012.08.033
Chicago Style (17th ed.) CitationAngel, Kristin, Sella Aarrestad Provan, Petter Mowinckel, Ingebjørg Seljeflot, Tore Kristian Kvien, and Dan Atar. "The L-arginine/asymmetric Dimethylarginine Ratio Is Improved by Anti-Tumor Necrosis Factor–α Therapy in Inflammatory Arthropathies. Associations with Aortic Stiffness." Atherosclerosis (00219150) 225, no. 1 (2012): 160. https://doi.org/10.1016/j.atherosclerosis.2012.08.033.
MLA (9th ed.) CitationAngel, Kristin, et al. "The L-arginine/asymmetric Dimethylarginine Ratio Is Improved by Anti-Tumor Necrosis Factor–α Therapy in Inflammatory Arthropathies. Associations with Aortic Stiffness." Atherosclerosis (00219150), vol. 225, no. 1, 2012, p. 160, https://doi.org/10.1016/j.atherosclerosis.2012.08.033.